Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Current Taxes (2021 - 2025)

Historic Current Taxes for Immucell (ICCC) over the last 5 years, with Q3 2025 value amounting to $3874.0.

  • Immucell's Current Taxes rose 23224.7% to $3874.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3874.0, marking a year-over-year increase of 23224.7%. This contributed to the annual value of $5815.0 for FY2024, which is 9059.32% up from last year.
  • Immucell's Current Taxes amounted to $3874.0 in Q3 2025, which was up 23224.7% from $5815.0 recorded in Q4 2024.
  • Immucell's Current Taxes' 5-year high stood at $5815.0 during Q4 2024, with a 5-year trough of $735.0 in Q2 2023.
  • Its 5-year average for Current Taxes is $3075.5, with a median of $3389.5 in 2022.
  • As far as peak fluctuations go, Immucell's Current Taxes crashed by 7414.16% in 2023, and later soared by 23224.7% in 2025.
  • Immucell's Current Taxes (Quarter) stood at $2141.0 in 2021, then surged by 128.4% to $4890.0 in 2022, then crashed by 37.61% to $3051.0 in 2023, then surged by 90.59% to $5815.0 in 2024, then plummeted by 33.38% to $3874.0 in 2025.
  • Its last three reported values are $3874.0 in Q3 2025, $5815.0 for Q4 2024, and $1166.0 during Q3 2024.